NA
REGN icon

Networth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Networth Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25K Hold
2
– – ﹤0.01% 314
2026
Q1 		$1.54K Hold
2
– – ﹤0.01% 305
2025
Q4 		$1.54K Buy
+2
New +$1.36K ﹤0.01% 277

Other funds holding REGN

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Networth Advisors's REGN Position: Q2 2026 in Review

Networth Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 2 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Networth Advisors first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.54K in Q1 2026. 675 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Networth Advisors held 2 shares of Regeneron Pharmaceuticals worth $1.25K as of Q2 2026.
  • Networth Advisors left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Networth Advisors's portfolio in Q2 2026, its #314 holding.
  • Networth Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Networth Advisors's Regeneron Pharmaceuticals position peaked at $1.54K in Q1 2026.
  • 675 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Networth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.